You are here

Kronik Böbrek Hastalarında ve Diyaliz Hastalarında 25 (OH) Vitamin D

25 (OH) Vitamin D in Patients with Chronic Kidney Disease and Dialysis Patients

Journal Name:

Publication Year:

DOI: 
DOI 10.5262/tndt.2012.1003.02

Keywords (Original Language):

Abstract (2. Language): 
In addition to its role on calcium homeostasis, vitamin D exhibits local (paracrine) effects on cell proliferation differentiation and immune function. Most cells in the body express Vitamin D receptors and 1α-hydroxylase, thereby permitting local production of 1,25 dihydroxycholecalciferol, which has therapeutic implications (paracrine effects). Studies have shown that chronic vitamin D deficiency may have serious adverse consequences such as increased risk of hypertension, multiple sclerosis, rheumatoid arthritis, cancer of the colon, prostate, breast, ovary, and type 1 diabetes. However, information about the effect of vitamin D supplementation and replacement, and cardiometabolic outcomes is very limited. Studies on Vitamin D replacement in patients with chronic kidney disease and dialysis patients are needed.
Abstract (Original Language): 
Vitamin D’nin kalsiyum hemostazının yanı sıra, hücre çoğalması, farklılaşması ve immün sistem üzerine lokal etkileri vardır. Vücutta birçok hücrede vitamin D reseptörü ve 1α hidroksilaz mevcuttur, dolayısıyla 1,25 dihidroksikolekalsiferol lokal sentezlenerek etki gösterir (parakrin etki). Yapılan çalışmalarda kronik vitamin D eksikliğinin hipertansiyon, multiple skleroz, romatoid artrit, kolon, prostat, meme, over kanseri ve tip 1 diyabet riskini arttırdığı gösterilmiştir. Ancak vitamin D yerine koyulmasının ve ilavesinin etkileri ve kardiyometabolik duruma etkileri hakkındaki bilgiler sınırlıdır. Kronik böbrek hastaları ve diyaliz hastalarında vitamin D (kolekalsiferol) yerine koyulmasının etkilerini inceleyen çalışmalara gerek vardır.

REFERENCES

References: 

1. Block GA, Port FK: Re-evaluation of risks associated with
hyperphosphatemia and hyperparathyroidism in dialysis patients:
Recommendations for a change in management. Am J Kidney Dis
2000; 35: 1226-1237
2. Moe SM, Drüeke TB, Block GA, Cannata-Andía JB, Elder GJ,
Fukagawa M, Jorgetti V, Ketteler M, Langman CB, Levin A,
MacLeod AM, McCann L, McCullough PA, Ott SM, Wang AY,
Weisinger JR, Wheeler DC, Persson R, Earley A, Moorthi R, Uhlig
K: KDIGO clinical practice guideline fort he diagnosis, evaluation,
prevention and treatment of Chronic Kidney Disease-Mineral and
Bone Disorder (CKD-MBD). Kidney Int Suppl 2009; 113: 1-130
3. Norman AW: Sunlight, season, skin pigmentation, vitamin D
and 25-hydroxyvitamin D: Integral components of the vitamin D
endocrine system. Am J Clin Nutr 1998; 67: 1108-1110
4. Holick MF: McCollum Award Lecture, 1994: Vitamin D-new
horizons for the 21st century. Am J Clin Nutr 1994; 60: 619-630
5. Holick MF: Sunlight and vitamin D for bone health and prevention
of autoimmune diseases, cancers, and cardiovascular disease. Am J
Clin Nutr 2004; 80 (6 Suppl): 1678-1688
6. Ross AC: The 2011 report on dietary reference intakes for calcium
and vitamin D. Public Health Nutr 2011; 14 (5): 938-939
7. Grant WB, Cross HS, Garland CF, Gorham ED, Moan J, Peterlik
M, Porojnicu AC, Reichrath J, Zittermann A: Estimated benefi t
of increased vitamin D status in reducing the economic burden
of disease in Western Europe. Prog Biophys Mol Biol 2009; 99:
104-113
8. Holick MF: Vitamin D Status: Measurement, Interpretation and
Clinical Application. Ann Epidemiol 2009; 19 (2): 73-78
9. Unal Y, Kindap T, Karaca M: Redefi ning the climate zones of
Turkey using cluster analysis. Int J Climatol 2003; 23: 1045-1055
10. Hekimsoy Z, Dinc G, Kafesciler S, Onur E, Guvenc Y, Pala T,
Guclu F, Ozmen B: Vitamin D status among adults in the Aegean
Region of Turkey. BMC Public Health 2010; 10: 782
11. Van der Wielen RP, Löwik MR, van den Berg H, de Groot LC, Haller
J, Moreiras O, van Staveren WA: Serum vitamin D concentrations
among elderly people in Europe. Lancet 1995; 346 (8969): 207-210
12. Gannagé-Yared MH, Chemali R, Yaacoub N, Halaby G:
Hypovitaminosis D in a sunny country: Relation to lifestyle and
bone markers. J Bone Miner Res 2000; 15(9): 1856-1862
13. Melamed ML, Michos ED, Post W, Astor B: 25-hydroxyvitamin
D levels and the risk of mortality in the general population. Arch
Intern Med 2008; 168 (15): 1629-1637
14. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier
K, Benjamin EJ, D’Agostino RB, Wolf M, Vasan RS: Vitamin D
deffi ciency and risk of cardiovascular disease. Circulation 2008;
117: 503-511
15. Autier P, Gandini S: Vitamin D supplementation and total mortality:
A meta-analysis of randomized controlled trials. Arch Intern Med
2007; 167 (16): 1730-1737
16. Mookherjee N, Rehaume LM, Hancock RE: Cathelicidins and
functional analogues as antisepsis molecules. Expert Opin Ther
Targets 2007; 11 (8): 993-1004
17. Gombart AF, Borregaard N, Koeffl er HP: Human cathelicidin
antimicrobial peptide (CAMP) gene is a direct target of the
vitamin D receptor and is strongly up-regulated in myeloid cells by
1,25-dihydroxyvitamin D3. FASEB J 2005; 19: 1067-1077
18. Aloia JF, Li-Nq M: Epidemic infl uenza and vitamin D. Epidemiol
Infect 2007; 135 (7): 1095-1098
19. Cantorna MT, Zhu Y, Froicu M, Wittke A: Vitamin D status,
1,25-dihydroxyvitamin D3 and the immune system. Am J Clinical
Nutr 2004; 80 (6): 1717-1720
20. Taskapan H, Ersoy FF, Passadakis PS, Tam P, Memmos DE,
Katopodis KP, Ozener C, Akcicek F, Camsari T, Ates K, Ataman R,
Vlachojannis JG, Dombros NA, Utas C, Akpolat T, Bozfakioglu S,
Wu G, Karayaylali I, Arinsoy T, Stathakis CP, Yavuz M, Tsakiris DJ,
Dimitriades AD, Yilmaz ME, Gultekin M, Oreopoulos DG: Severe
vitamin D defi ciency in chronic renal failure patients on peritoneal
dialysis. Clin Nephrol 2006; 66 (4): 247-255
21. Ravani P, Malberti F, Tripepi G, Pecchini P, Cutrupi S, Pizzini P,
Mallamaci F, Zoccali C: Vitamin D levels and patient outcome in
chronic kidney disease. Kidney Int 2009; 75 (1): 88-95
22. Kendrick J, Targher G, Smits G, Chonchol M: 25-Hydroxyvitamin D
defi ciency and infl ammation and their association with hemoglobin
levels in chronic kidney disease. Am J Nephrol 2009; 30 (1): 64-72
23. Wang AY, Lam CW, Sanderson JE, Wang M, Chan IH, Lui SF, Sea
MM, Woo J: Serum 25-hydroxyvitamin D status and cardiovascular
outcomes in chronic peritoneal dialysis patients: A 3-y prospective
cohort study. Am J Clin Nutr 2008; 87 (6): 1631-1638
24. Drechsler C, Pilz S, Obermayer-Pietsch B, Verduijn M, Tomaschitz
A, Krane V, Espe K, Dekker F, Brandenburg V, März W, Ritz
E, Wanner C: Vitamin D defi ciency is associated with sudden
cardiac death, combined cardiovascular events and mortality in
haemodialysis patients. Eur Heart J 2010; 31 (18): 2253-2261
25. Taskapan H, Ersoy FF, Passadakis P, Tam P, Memmos D,
Katopodis K, Ozener C, Akcicek F, Camsari T, Ates K, Ataman R,
Vlachojannis JG, Dombros N, Utas C, Akpolat T, Bozfakioglu S,
Wu GG, Karayaylalı I, Arınsoy T, Stathakis Ch, Yavuz M, Tsakiris
D, Dimitriades A, Yılmaz ME, Gultekin M, Karayalcın B, Polat N,
Oreopoulos DG: Body pain during daily activities in patients on
peritoneal dialysis. Dialysis and Transplantation 2005; 2: 58-72
26. Bindal ME, Taskapan H: Hypovitaminosis D and insulin resistance
in peritoneal dialysis patients. Int Urol Nephrol 2011; 43 (2):
527-534
27. Gal-Moscovici A, Sprague SM: Role of Vitamin D defi ciency in
chronic kidney Disease. J Bone Miner Res 2007; 22: 91-94
28. Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart
PM, Hewison M: Extrarenal expression of 25-hydroxyvitamin
d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 2001; 86 (2):
888-894
29. Tokmak F, Quack I, Schieren G, Sellin L, Rattensperger D, Holland-
Letz T, Weiner SM, Rump LC: High-dose cholecalciferol to correct
vitamin D defi ciency in haemodialysis patients. Nephrol Dial
Transplant 2008; 23: 4016-4020
30. Zhang Z, Sun L, Wang Y, Ning G, Minto AW, Kong J, Quigg RJ,
Li YC: Renoprotective role of the vitamin D receptor in diabetic
nephropathy. Kidney Int 2008; 73 (2): 163-171
31. Taskapan H, Baysal O, Karahan D, Durmus B , Altay Z, Ulutas O:
Vitamin D and muscle strength, functional and balance ability in
peritoneal dialysis patients with vitamin D defi ciency. Clin Nephrol
2011; 76 (2): 110-116
32. Pittas AG, Chung M, Trikalinos T, Mitri J, Brendel M, Patel K,
Lichtenstein AH, Lau J, Balk EM: Systematic review: Vitamin D
and cardiometabolic outcomes. Ann Intern Med 2010; 152 (5):
307-314

Thank you for copying data from http://www.arastirmax.com